TMCnet News

Genome Editing/Genome Engineering Market - Expected to Reach $6.2 Billion by 2022 - Research and Markets
[December 11, 2017]

Genome Editing/Genome Engineering Market - Expected to Reach $6.2 Billion by 2022 - Research and Markets


The "Genome Editing/Genome Engineering Market - Global Forecast 2022" report has been added to Research and Markets' offering.

The global genome editing market is expected to grow at a CAGR of 14.5% to reach to USD 6.28 billion by 2022. The key factors propelling the growth of this market are rising government funding and growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics.

By technology, the market is segmented into CRISPR, TALEN, ZFN, antisense, and other technologies (PiggyBac, Flp-In, Adenine Base Editor (ADE (News - Alert)), and Jump-In). The CRISPR segment is estimated to grow at the highest CAGR during the forecast period. The ease of use associated with the CRISPR technology is a significant advantage over ZFN and TALEN, especially in generating a large set of vectors to target numerous sites or even genome-wide libraries. Another potential advantage of CRISPR is its aility to multiplex, that is, to use multiple guide RNAs in parallel to target multiple sites simultaneously in the same cell. This makes it easier to mutate multiple genes at once or engineer precise deletions in a genomic region.



On the basis of end user, the market is classified into pharmaceutical and biotechnology companies, academic & government research institutes, and contract research organizations. The pharmaceutical and biotechnology companies segment is estimated to grow at the fastest rate during the forecast period. The increasing prevalence of infectious diseases and cancer are driving research activities worldwide; this is expected to drive the demand for genome editing in biotechnology & pharmaceutical companies.

Companies Mentioned


  • Crispr Therapeutics
  • Editas Medicine
  • Genscript
  • Horizon Discovery Group
  • Integrated Dna Technologies
  • Lonza
  • Merck
  • New England Biolabs
  • Origene Technologies
  • Sangamo Biosciences
  • Thermo Fisher Scientific
  • Transposagen Biopharmaceuticals

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Genome Editing Market, By Technology

7 Genome Editing Market, By Application

8 Genome Editing Market, By End User

9 Genome Editing Market, By Region

10 Competitive Landscape

11 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/lhfpvw/genome


[ Back To TMCnet.com's Homepage ]